Hochschulschrift
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Clinical Medicine 12 (2023) 4, 1356, 1-18
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2023
- Creator
-
Semo, Dilvin
Obergassel, Julius
Dorenkamp, Marc
Hemling, Pia
Strutz, Jasmin
Hiden, Ursula
Müller, Nicolle
Müller, Ulrich Alfons
Zulfikar, Sajan Ahmad
Godfrey, Rinesh
Waltenberger, Johannes
- DOI
-
10.17879/88938519989
- URN
-
urn:nbn:de:hbz:6-68938634138
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Semo, Dilvin
- Obergassel, Julius
- Dorenkamp, Marc
- Hemling, Pia
- Strutz, Jasmin
- Hiden, Ursula
- Müller, Nicolle
- Müller, Ulrich Alfons
- Zulfikar, Sajan Ahmad
- Godfrey, Rinesh
- Waltenberger, Johannes
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2023
Other Objects (12)
The sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin reverses hyperglycemia-induced monocyte and endothelial dysfunction primarily through glucose-transport independent, but redox-dependent mechanisms
Monocyte function and dysfunction in hypercholesterolemia
Effects of the sodium-glucose cotransporter 2 inhibitors Canagliflozin, Dapagliflozin and Empagliflozin on endothelial barrier dysfunction : An in-vitro study
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Kinetic Determination of Glucose Concentrations with Glucose Dehydrogenase
Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflüssigkeiten
Glucose-Infusionslösung: 50
Glucose-Infusionslösung: 100
Glucose-Nährbouillon, 168
Glucose/Glukose-Infusionslösungen
Glucose-Infusionslösung: 200
The sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin reverses hyperglycemia-induced monocyte and endothelial dysfunction primarily through glucose-transport independent, but redox-dependent mechanisms
Monocyte function and dysfunction in hypercholesterolemia
Effects of the sodium-glucose cotransporter 2 inhibitors Canagliflozin, Dapagliflozin and Empagliflozin on endothelial barrier dysfunction : An in-vitro study
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Kinetic Determination of Glucose Concentrations with Glucose Dehydrogenase
Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflüssigkeiten
Glucose-Infusionslösung: 50
Glucose-Infusionslösung: 100
Glucose-Nährbouillon, 168
Glucose/Glukose-Infusionslösungen
Glucose-Infusionslösung: 200
The sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin reverses hyperglycemia-induced monocyte and endothelial dysfunction primarily through glucose-transport independent, but redox-dependent mechanisms
Monocyte function and dysfunction in hypercholesterolemia
Effects of the sodium-glucose cotransporter 2 inhibitors Canagliflozin, Dapagliflozin and Empagliflozin on endothelial barrier dysfunction : An in-vitro study
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Kinetic Determination of Glucose Concentrations with Glucose Dehydrogenase
Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflüssigkeiten
Glucose-Infusionslösung: 50
Glucose-Infusionslösung: 100
Glucose-Nährbouillon, 168
Glucose/Glukose-Infusionslösungen